Gamida Cell Liabilities 2024

Gamida Cell Liabilities

132.8 M USD

Gamida Cell Dividend yield

Ticker

GMDA

ISIN

IL0011552663

WKN

A2N7XM

In 2024, Gamida Cell's total liabilities amounted to 132.8 M USD, a 26.72% difference from the 104.8 M USD total liabilities in the previous year.

Gamida Cell Aktienanalyse

What does Gamida Cell do?

The company Gamida Cell Ltd was founded in 1998 in Jerusalem, Israel and is involved in the development and manufacture of cell therapy products for various diseases. The company has had an exciting history since its inception, including a number of successes and milestones. Gamida Cell's business model is based on the production of cell therapy products for patients suffering from severe diseases. These include blood diseases such as leukemia, lymphoma, or sickle cell anemia. The company uses a unique technology platform called "NiCord," which allows for the extraction and expansion of cells from umbilical cord blood to provide a larger number of cells for transplantation. This platform offers a way to overcome some of the limitations and challenges associated with the use of bone marrow or stem cell donors. Gamida Cell has made significant progress in the development of cell therapy products in recent years. The company is currently working on the development of therapies for various indications such as blood diseases, solid tumors, and autoimmune diseases. Another goal of Gamida Cell is to use its technology platform for the development of drugs for other indications. The company has various divisions in which it operates. The primary division is research and development of cell therapies. However, the company also has a manufacturing facility for the production of its products and a clinical studies department responsible for conducting studies and tests of therapeutics. Gamida Cell collaborates closely with research institutions and other companies in the biotechnology industry to further develop its technology platform and advance the progress of cell therapies overall. Gamida Cell currently offers a range of products, starting with its flagship product "NiCord." NiCord is a cell therapy made from umbilical cord blood cells and can be used for transplantation in patients with blood diseases such as leukemia or lymphoma. The company is also working on the development of additional products, including a cell therapy for solid tumors and a treatment for autoimmune diseases. In recent years, Gamida Cell has received several awards and recognitions. The company has attracted several leading scientists and researchers who collaborate closely with Gamida Cell to further develop the company's technology platform and create new therapies. At the same time, Gamida Cell has also carried out several capital increases to advance research and product development. Overall, Gamida Cell has an excellent reputation in the biotech industry. The company has shown that it can play a leading role in the development of cell therapies that can improve the lives of patients with severe diseases. With the growing demand for new treatment options and the rapid progress in the field of biotech, Gamida Cell is well positioned to continue expanding and developing new therapies that have the potential to change the lives of millions of people worldwide. Gamida Cell ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Liabilities Details

Assessing Gamida Cell's Liabilities

Gamida Cell's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Gamida Cell's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Gamida Cell's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Gamida Cell's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Gamida Cell’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Gamida Cell Stock

What is the level of liabilities of Gamida Cell this year?

Gamida Cell has a debt balance of 132.8 M USD this year.

What were the liabilities of Gamida Cell compared to the previous year?

The liabilities of Gamida Cell have increased by 26.72% increased compared to the previous year.

What are the consequences of high debt for investors of Gamida Cell?

High liabilities can pose a risk for investors of Gamida Cell, as they can weaken the company's financial position and impair its ability to meet its obligations.

What consequences do low liabilities have for investors in Gamida Cell?

Low liabilities mean that Gamida Cell has a strong financial position and is able to meet its obligations without overburdening its finances.

How does an increase in liabilities of Gamida Cell affect the company?

An increase in liabilities of Gamida Cell can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.

How does a reduction in the liabilities of Gamida Cell affect the company?

A decrease in the liabilities of Gamida Cell can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.

What are some factors that influence the liabilities of Gamida Cell?

Some factors that can influence the liabilities of Gamida Cell include investments, acquisitions, operating costs, and sales development.

Why is the level of liabilities of Gamida Cell so important for investors?

The liabilities of Gamida Cell are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.

What strategic measures can Gamida Cell take to modify the liabilities?

To change its liabilities, Gamida Cell can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.

How much dividend does Gamida Cell pay?

Over the past 12 months, Gamida Cell paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Gamida Cell is expected to pay a dividend of 0 USD.

What is the dividend yield of Gamida Cell?

The current dividend yield of Gamida Cell is .

When does Gamida Cell pay dividends?

Gamida Cell pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Gamida Cell?

Gamida Cell paid dividends every year for the past 0 years.

What is the dividend of Gamida Cell?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Gamida Cell located?

Gamida Cell is assigned to the 'Health' sector.

Wann musste ich die Aktien von Gamida Cell kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Gamida Cell from 3/29/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 3/29/2024.

When did Gamida Cell pay the last dividend?

The last dividend was paid out on 3/29/2024.

What was the dividend of Gamida Cell in the year 2023?

In the year 2023, Gamida Cell distributed 0 USD as dividends.

In which currency does Gamida Cell pay out the dividend?

The dividends of Gamida Cell are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Gamida Cell

Our stock analysis for Gamida Cell Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Gamida Cell Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.